Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,392.28
(
-0.22%
)
US TECH 100
28,164.00
(
-0.68%
)
Dow Jones
49,705.51
(
0.36%
)
Brent Oil
106.98
(
-0.46%
)
Bitcoin
76,352.54
(
-1.36%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: zipjet post# 64975

Sunday, 08/03/2008 1:03:24 PM

Sunday, August 03, 2008 1:03:24 PM

Post# of 257580
>The T franchise is now burdened with the risk that sales will be discontinued. Pulling the drug could happen any time.<

The salient point, IMO, is that Tysabri will not reach the stated goal of 100,000 patients in 2010 and it probably won’t even come close.

Whether Ty would have reached this goal in any case was debatable, but now the chances of its doing so are virtually nil.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today